SOX2 and malignant glioma: In our previous study we detected the stem cell marker and transcription factor SOX2 in glioblastoma tissue and glioblastoma cell lines [8] and hypothesized that it might represent an ideal target for an experimental RNAi approach for treatment of malignant gliomas.